4. Ostrava CSF symposium

NOTICE: The validity of the information on this page has expired.

Date

September 6, 2019
University of Ostrava, Faculty of Medicine, Building INLEK, conference hall

Program

9:00 – 9:30 Registration

9:30-10:45 Part I

Biomarkers of multiple sclerosis
(Zeman D., Hradílek P., Mareš J.)

1) Wurster U. (Liquorlabor, Medizinische Hochschule Hannover, Germany): Comparison of three commercially available methods for the detection of oligoclonal IgG (20 min)

2) Zeman D., Kušnierová P., Hradílek P. ( Institute of Laboratory Diagnostics, Department of Clinical Biochemistry, University Hospital Ostrava, Clinic of Neurology, University Hospital Ostrava, Medical Faculty, University of Ostrava): Project „CSF biomarkers of multiple sclerosis“ – main results (20 min)

3) Baranovičová E., Čierny D., Dobrota D., Michalík J., Jankovičová N., Kurča E., Kantorová E. (Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia): CSF metabolic profile of patients with multiple sclerosis and clinically isolated syndrome compared to other CNS demyelinating diseases and healthy controls (20 min)

4) Porubová P., Zeman D., Hradílek P., Zapletalová O., Kušnierová P., Stejskal D., Mareš J. (University of Ostrava, Institute of Laboratory Diagnostics, Department of Clinical Biochemistry, University Hospital Ostrava, Clinic of Neurology, University Hospital Ostrava, Medical Faculty, University of Ostrava; Clinic of Neurology, University Hospital Olomouc): Laboratory monitoring of MS patients treated by interferon beta preparations (15 min)

10:45 – 11:00 coffee break

11:00-12:20 Part II

Biomarkers of neurodegenerative diseases
(Gmitterová K., Kušnierová P.)

1) Gmitterová K. (II. Clinic of Neurology, Dérer University Hospital and Faculty of Medicine, Comenius University, Bratislava, Slovakia): Biomarkers of neurodegenerative diseases – potential impact on clinical practice (20 min)

2) Roubalová L. (University Hospital Olomouc, CZ): Practical experience with examination of Triplet biomarkers Total-Tau, Phospho-Tau and b-Amyloid (1-42) in University Hospital Olomouc (20 min)

3) Kušnierová P., Zagorová H., Zeman D. (University of Ostrava, University Hospital Ostrava).: Aβ42, total tau and phospho-tau: Method comparison (20 min)

4) Smětáková M. (Department of Pathology and Molecular Medicine of 3rd Medical Faculty, Charles University, Thomayer Hospital, Prague): Protein 14-3-3: Non-specific marker of neuronal decay (20 min)

12:20 – 13:00 Lunch

13:00 – 14:25 Part III

Neuroimmunology
(Thon V., Král V.)

1) Nazarov V. (Laboratory of autoimmune diagnostics, St. Petersburg Pavlov Medical University, St. Petersburg, Russia): Role of immunological laboratory in the diagnosis of neurological diseases (30 min)

2) Makshakov G. (St. Petersburg´s Center of MS and autoimmune diseases, City Hospital No. 31, St. Petersburg, Russia): Case reports (15 min)

3) Král V., Pohořská J. (Center of Immunology and Microbiology, Public Health Institute, Ústí nad Labem, Czech Republic): Current possibilities of the determination of autoantibodies in CNS diseases – personal experience (20 min)

4) Thon V. (Recetox, Masarykova univerzita, Brno; AKIMED, Brno): Principles of immunomodulation and immune system reconstitution in multiple sclerosis (20 min.)

14:25 – 14:45 coffee break

14:45 – 16:15 Part IV

Neurotropic infectious agents
(Sobek O., Petroušová L.)

1) Petroušová L. (Clinic of infectious diseases, University Hospital Ostrava): Diagnostics of CNS infections in clinical practice (30 min)

2) Sobek O. (Topelex, Prague): Aspects of CSF analysis in neuroborreliosis (25 min)

3) Kelbich P., Radovnický T. (Biomedical Center of Masaryk Hospital in Ústí nad Labem, Neurosurgical Clinic of J. E. Purkyně University and Masaryk Hospital in Ústí nad Labem): CSF diagnostics of CNS damage during the early postnatal period (20 min)

16:15 – 16:30 Discussion

Updated: 18. 11. 2022